Phase I Study of the Administration of EBV CTLs Expressing CD30 Chimeric Receptors (CAR.CD30) for Relapsed CD30 Hodgkin Lymphoma and CD30 Non-Hodgkin Lymphoma - CD30 - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-12-31 14:00:44 T helper cell T cells CD30 Chimeric antigen receptor		Phase I Study of the Administration of EBV CTLs Expressing CD30 Chimeric Receptors (CAR.CD30) for Relapsed CD30+ Hodgkin Lymphoma and CD30+ Non-Hodgkin Lymphoma Add to Reading List Source URL: osp.od.nih.gov Download Document from Source Website File Size: 780,23 KB Share Document on Facebook